Summit Therapeutics Gestione
Gestione criteri di controllo 2/4
Summit Therapeutics Il CEO è Bob Duggan, nominato in Jul2022, ha un mandato di 2.33 anni. possiede direttamente 74.81% delle azioni della società, per un valore di $ 11.03B. La durata media del mandato del team dirigenziale e del consiglio di amministrazione è rispettivamente 2.3 anni e 4.5 anni.
Informazioni chiave
Bob Duggan
Amministratore delegato
n/a
Compenso totale
| Percentuale dello stipendio del CEO | n/a |
| Mandato del CEO | 2.3yrs |
| Proprietà del CEO | 74.8% |
| Durata media del management | 2.3yrs |
| Durata media del Consiglio di amministrazione | 4.5yrs |
Aggiornamenti recenti sulla gestione
Recent updates
Summit Therapeutics (NASDAQ:SMMT) Has Debt But No Earnings; Should You Worry?
Nov 08
Summit Therapeutics: Cancer Drug With Great Potential On 'Fast Track' To US Market
Oct 04Summit Therapeutics Bests Merck's Top Selling Drug In Phase III Trial
Sep 19Summit Therapeutics: World Lung Data Not Enough For Ivonescimab To Unseat Keytruda (Yet)
Sep 09Summit Therapeutics May Have Further Upside From Here
Aug 03Summit Therapeutics Stock: Plunging Despite A Win?
May 31Summit Therapeutics' Ivonescimab: Strong Buy Its Dual-Action Approach To Cancer
May 06Summit Therapeutics: A Strategic Analysis Of Ivonescimab's Progress
Jan 30We're Hopeful That Summit Therapeutics (NASDAQ:SMMT) Will Use Its Cash Wisely
Dec 29Summit Therapeutics slips on plans to terminate study for lead candidate
Oct 04Summit Therapeutics: Developing Antibiotics Is A Noble Cause But The Company Is Wise To Expand Its Portfolio
Aug 17Summit Therapeutics GAAP EPS of -$0.17, revenue of $0.23M
Aug 11Summit to explore additional trial for its bacteria-induced colon infection drug
Jul 14Here's Why We're Watching Summit Therapeutics' (NASDAQ:SMMT) Cash Burn Situation
Apr 29Summit Therapeutics - Disappointing Data But Not An Outright Failure
Dec 23Summit Therapeutics: A Full Investment Analysis Of This Antibiotic Innovator
Jun 22Summit Therapeutics to join Russell 3000 Index
Jun 08AMMINISTRATORE DELEGATO
Bob Duggan (80 yo)
2.3yrs
Mandato
Mr. Robert W. Duggan, also known as Bob, had been an Interim Principal Financial Officer at Summit Therapeutics Inc. since July 02, 2021. He served as the Co-Chief Executive Officer at Summit Therapeutics...
Gruppo dirigente
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-CEO & Executive Chairman | 2.3yrs | Nessun dato | 74.81% $ 11.0b | |
| Co-CEO, President & Director | 2.3yrs | US$20.56m | 4.85% $ 714.8m | |
| COO, CFO & Director | 1.1yrs | US$23.97m | 0.41% $ 60.4m | |
| Co-Founder | no data | Nessun dato | Nessun dato | |
| Chief Accounting Officer & Head of Finance | less than a year | Nessun dato | 0.018% $ 2.6m | |
| Head of Human Resources | 1.6yrs | Nessun dato | Nessun dato | |
| Head of Global Clinical Operations | 4.7yrs | Nessun dato | Nessun dato | |
| Chief Business & Strategy Officer | no data | Nessun dato | Nessun dato | |
| Head of Research | 3.4yrs | Nessun dato | Nessun dato | |
| Chief Biometrics Officer | 3.8yrs | Nessun dato | Nessun dato | |
| Chief Education & Brand Officer | 1.8yrs | Nessun dato | Nessun dato | |
| Head of Clinical Pharmacology & DMPK | 3.3yrs | Nessun dato | Nessun dato |
2.3yrs
Durata media
56yo
Età media
Gestione esperta: Il team dirigenziale di SMMT è considerato esperto (durata media dell'incarico 2.3 anni).
Membri del Consiglio di amministrazione
| Nome | Posizione | Mandato | Compensazione | Proprietà |
|---|---|---|---|---|
| Co-CEO & Executive Chairman | 4.9yrs | Nessun dato | 74.81% $ 11.0b | |
| Co-CEO, President & Director | 4yrs | US$20.56m | 4.85% $ 714.8m | |
| COO, CFO & Director | 4.9yrs | US$23.97m | 0.41% $ 60.4m | |
| Co-Founder | no data | Nessun dato | Nessun dato | |
| Lead Independent Director | 3.1yrs | US$334.65k | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory Board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory board | no data | Nessun dato | Nessun dato | |
| Member of Scientific Advisory board | no data | Nessun dato | Nessun dato |
4.5yrs
Durata media
65yo
Età media
Consiglio di amministrazione esperto: I membri del consiglio di amministrazione di SMMT sono considerati esperti (durata media dell'incarico 4.5 anni).